TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs3809272
log Bayes Factor = 28.191
Chromosome 12   position 111,800,258  (GRCh37) Explore rs3809272 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
I25 Chronic ischaemic heart disease
0.000 0.000 1.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes
1.000 0.000 0.000
I25.1 Atherosclerotic heart disease
0.000 0.000 1.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
1.000 0.000 0.000
I21 Acute myocardial infarction
0.000 0.000 1.000
C79 Secondary malignant neoplasm of other sites
1.000 0.000 0.000
C77.3 Axillary and upper limb lymph nodes
1.000 0.000 0.000
I20-I25 Ischaemic heart diseases
0.000 0.000 1.000
I21.1 Acute transmural myocardial infarction of inferior wall
0.000 0.001 0.999
I21.0 Acute transmural myocardial infarction of anterior wall
0.000 0.005 0.995
I25.9 Chronic ischaemic heart disease, unspecified
0.000 0.012 0.988
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.982 0.018 0.000
C78.7 Secondary malignant neoplasm of liver
0.982 0.018 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.981 0.019 0.000
C77.1 Intrathoracic lymph nodes
0.978 0.022 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.963 0.037 0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.958 0.042 0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.947 0.053 0.000
E03 Other hypothyroidism
0.000 0.054 0.946
E20-E35 Disorders of other endocrine glands
0.000 0.062 0.938
E27 Other disorders of adrenal gland
0.000 0.066 0.934
I25.8 Other forms of chronic ischaemic heart disease
0.000 0.070 0.930
I25.2 Old myocardial infarction
0.000 0.074 0.926
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.079 0.921
E00-E07 Disorders of thyroid gland
0.000 0.087 0.913
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.088 0.912
I22 Subsequent myocardial infarction
0.000 0.089 0.911
E21.3 Hyperparathyroidism, unspecified
0.000 0.098 0.902
E27.1 Primary adrenocortical insufficiency
0.000 0.098 0.902
C77.8 Lymph nodes of multiple regions
0.894 0.106 0.000
I22.1 Subsequent myocardial infarction of inferior wall
0.000 0.113 0.887
E27.2 Addisonian crisis
0.000 0.122 0.878
I21.2 Acute transmural myocardial infarction of other sites
0.000 0.124 0.876
E21.0 Primary hyperparathyroidism
0.000 0.140 0.860
E40-E46 Malnutrition
0.000 0.140 0.860
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.857 0.143 0.000
C79.6 Secondary malignant neoplasm of ovary
0.838 0.161 0.000
E23 Hypofunction and other disorders of pituitary gland
0.000 0.171 0.829
E46 Unspecified protein-energy malnutrition
0.000 0.178 0.822
C78.4 Secondary malignant neoplasm of small intestine
0.793 0.207 0.000
C77.5 Intrapelvic lymph nodes
0.789 0.211 0.000
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.212 0.788
C77.9 Lymph node, unspecified
0.785 0.215 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.782 0.218 0.000
I20 Angina pectoris
0.000 0.219 0.781
E34 Other endocrine disorders
0.000 0.227 0.773
E27.8 Other specified disorders of adrenal gland
0.000 0.236 0.764
I23 Certain current complications following acute myocardial infarction
0.000 0.239 0.761
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.242 0.758
I25.3 Aneurysm of heart
0.000 0.244 0.756
C77.0 Lymph nodes of head, face and neck
0.756 0.244 0.000
E24 Cushing's syndrome
0.000 0.248 0.752
E10-E14 Diabetes mellitus
0.000 0.248 0.752
I21.3 Acute transmural myocardial infarction of unspecified site
0.000 0.251 0.749
E23.6 Other disorders of pituitary gland
0.000 0.256 0.744
I25.4 Coronary artery aneurysm
0.000 0.258 0.742
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.734 0.266 0.000
E20 Hypoparathyroidism
0.000 0.269 0.731
E10 Insulin-dependent diabetes mellitus
0.000 0.272 0.728
I20.1 Angina pectoris with documented spasm
0.000 0.278 0.722
I25.0 Atherosclerotic cardiovascular disease, so described
0.000 0.279 0.721
I21.X Presumed acute myicardial infaction (unconfirmed)
0.000 0.283 0.717
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.697 0.303 0.000
C78.0 Secondary malignant neoplasm of lung
0.697 0.303 0.000
E10.5 With peripheral circulatory complications
0.000 0.304 0.696
I22.0 Subsequent myocardial infarction of anterior wall
0.000 0.307 0.692
C79.2 Secondary malignant neoplasm of skin
0.690 0.310 0.000
E03.1 Congenital hypothyroidism without goitre
0.000 0.311 0.689
I20.9 Angina pectoris, unspecified
0.000 0.314 0.686
E03.5 Myxoedema coma
0.000 0.322 0.678
E03.4 Atrophy of thyroid (acquired)
0.000 0.322 0.678
E03.3 Postinfectious hypothyroidism
0.000 0.322 0.678
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.322 0.678
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.322 0.678
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.327 0.673
E32 Diseases of thymus
0.000 0.327 0.673
E31 Polyglandular dysfunction
0.000 0.327 0.673
E30 Disorders of puberty, not elsewhere classified
0.000 0.327 0.673
E25 Adrenogenital disorders
0.000 0.327 0.673
E27.5 Adrenomedullary hyperfunction
0.000 0.330 0.670
E27.0 Other adrenocortical overactivity
0.000 0.330 0.670
E23.0 Hypopituitarism
0.000 0.331 0.669
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.332 0.668
E26 Hyperaldosteronism
0.000 0.334 0.666
E10.1 With ketoacidosis
0.000 0.334 0.666
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.338 0.662
E23.2 Diabetes insipidus
0.000 0.341 0.659
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.656 0.343 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.345 0.655
E00 Congenital iodine-deficiency syndrome
0.000 0.345 0.655
I25.6 Silent myocardial ischaemia
0.000 0.353 0.647
E27.9 Disorder of adrenal gland, unspecified
0.000 0.360 0.640
E10.2 With renal complications
0.000 0.361 0.639
E06 Thyroiditis
0.000 0.367 0.633
E21.2 Other hyperparathyroidism
0.000 0.369 0.631
E03.8 Other specified hypothyroidism
0.000 0.371 0.629
E24.2 Drug-induced Cushing's syndrome
0.000 0.380 0.620
C77.4 Inguinal and lower limb lymph nodes
0.618 0.382 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.384 0.616
E45 Retarded development following protein-energy malnutrition
0.000 0.384 0.616
E43 Unspecified severe protein-energy malnutrition
0.000 0.384 0.616
E42 Marasmic kwashiorkor
0.000 0.384 0.616
E41 Nutritional marasmus
0.000 0.384 0.616
E40 Kwashiorkor
0.000 0.384 0.616
I25.5 Ischaemic cardiomyopathy
0.000 0.390 0.610
E29 Testicular dysfunction
0.000 0.396 0.604
E34.9 Endocrine disorder, unspecified
0.000 0.397 0.603
E28 Ovarian dysfunction
0.000 0.401 0.599
E22 Hyperfunction of pituitary gland
0.000 0.401 0.599
C76 Malignant neoplasm of other and ill-defined sites
0.598 0.401 0.000
E34.0 Carcinoid syndrome
0.000 0.405 0.595
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.406 0.594
E23.1 Drug-induced hypopituitarism
0.000 0.406 0.594
I23.8 Other current complications following acute myocardial infarction
0.000 0.410 0.590
E34.8 Other specified endocrine disorders
0.000 0.415 0.585
C78.2 Secondary malignant neoplasm of pleura
0.585 0.415 0.000
E20.9 Hypoparathyroidism, unspecified
0.000 0.418 0.582
E10.4 With neurological complications
0.000 0.427 0.573
E24.9 Cushing's syndrome, unspecified
0.000 0.427 0.573
C80 Malignant neoplasm without specification of site
0.573 0.427 0.000
E34.5 Androgen resistance syndrome
0.000 0.446 0.554
E34.4 Constitutional tall stature
0.000 0.446 0.554
E34.3 Short stature, not elsewhere classified
0.000 0.446 0.554
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.446 0.554
E34.1 Other hypersecretion of intestinal hormones
0.000 0.446 0.554
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction
0.000 0.454 0.546
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction
0.000 0.454 0.546
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction
0.000 0.454 0.546
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction
0.000 0.454 0.546
I23.2 Ventricular septal defect as current complication following acute myocardial infarction
0.000 0.454 0.546
I23.1 Atrial septal defect as current complication following acute myocardial infarction
0.000 0.454 0.546
I23.0 Haemopericardium as current complication following acute myocardial infarction
0.000 0.454 0.546
E24.8 Other Cushing's syndrome
0.000 0.461 0.539
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.461 0.539
E24.3 Ectopic ACTH syndrome
0.000 0.461 0.539
E24.1 Nelson's syndrome
0.000 0.461 0.539
E12 Malnutrition-related diabetes mellitus
0.000 0.461 0.539
E20.8 Other hypoparathyroidism
0.000 0.476 0.524
E20.1 Pseudohypoparathyroidism
0.000 0.476 0.524
E20.0 Idiopathic hypoparathyroidism
0.000 0.476 0.524
E10.7 With multiple complications
0.000 0.478 0.522
C78.1 Secondary malignant neoplasm of mediastinum
0.518 0.481 0.000
I22.8 Subsequent myocardial infarction of other sites
0.000 0.486 0.514
E21.4 Other specified disorders of parathyroid gland
0.000 0.488 0.511
E13 Other specified diabetes mellitus
0.000 0.490 0.510
E26.0 Primary hyperaldosteronism
0.000 0.492 0.508
E10.0 With coma
0.000 0.494 0.506
E24.0 Pituitary-dependent Cushing's disease
0.000 0.505 0.495
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.507 0.492
E22.1 Hyperprolactinaemia
0.000 0.508 0.492
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.512 0.488
E06.3 Autoimmune thyroiditis
0.000 0.515 0.485
E25.9 Adrenogenital disorder, unspecified
0.000 0.517 0.482
E25.8 Other adrenogenital disorders
0.000 0.517 0.482
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.517 0.482
E30.9 Disorder of puberty, unspecified
0.000 0.517 0.482
E30.8 Other disorders of puberty
0.000 0.517 0.482
E30.1 Precocious puberty
0.000 0.517 0.482
E30.0 Delayed puberty
0.000 0.517 0.482
E31.9 Polyglandular dysfunction, unspecified
0.000 0.517 0.482
E31.8 Other polyglandular dysfunction
0.000 0.517 0.482
E31.1 Polyglandular hyperfunction
0.000 0.517 0.482
E31.0 Autoimmune polyglandular failure
0.000 0.517 0.482
E32.9 Disease of thymus, unspecified
0.000 0.517 0.482
E32.8 Other diseases of thymus
0.000 0.517 0.482
E32.1 Abscess of thymus
0.000 0.517 0.482
E32.0 Persistent hyperplasia of thymus
0.000 0.517 0.482
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.517 0.482
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.517 0.482
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.517 0.482
E14 Unspecified diabetes mellitus
0.000 0.521 0.479
E10.8 With unspecified complications
0.000 0.521 0.479
E26.8 Other hyperaldosteronism
0.000 0.522 0.478
E26.1 Secondary hyperaldosteronism
0.000 0.522 0.478
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.530 0.469
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.530 0.469
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.530 0.469
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.530 0.469
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.530 0.469
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.530 0.469
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.530 0.469
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.530 0.469
E10.6 With other specified complications
0.000 0.533 0.467
C76.2 Abdomen
0.458 0.541 0.000
E06.4 Drug-induced thyroiditis
0.000 0.546 0.454
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.546 0.454
E06.1 Subacute thyroiditis
0.000 0.546 0.454
E06.0 Acute thyroiditis
0.000 0.546 0.454
E06.5 Other chronic thyroiditis
0.000 0.556 0.443
E28.3 Primary ovarian failure
0.000 0.557 0.443
E44.1 Mild protein-energy malnutrition
0.000 0.558 0.442
E44.0 Moderate protein-energy malnutrition
0.000 0.558 0.442
C80.9 Malignant neoplasm, unspecified
0.440 0.560 0.000
E07 Other disorders of thyroid
0.000 0.563 0.436
E26.9 Hyperaldosteronism, unspecified
0.000 0.566 0.433
E29.9 Testicular dysfunction, unspecified
0.000 0.566 0.433
E29.8 Other testicular dysfunction
0.000 0.566 0.433
E29.0 Testicular hyperfunction
0.000 0.566 0.433
E28.9 Ovarian dysfunction, unspecified
0.000 0.570 0.430
E28.8 Other ovarian dysfunction
0.000 0.570 0.430
E28.1 Androgen excess
0.000 0.570 0.430
E28.0 Oestrogen excess
0.000 0.570 0.430
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.570 0.429
E22.8 Other hyperfunction of pituitary gland
0.000 0.570 0.429
C76.8 Overlapping lesion of other and ill-defined sites
0.429 0.571 0.000
C76.7 Other ill-defined sites
0.429 0.571 0.000
C76.5 Lower limb
0.429 0.571 0.000
C76.4 Upper limb
0.429 0.571 0.000
E10.3 With ophthalmic complications
0.000 0.576 0.424
C76.0 Head, face and neck
0.421 0.579 0.000
E14.3 With ophthalmic complications
0.000 0.589 0.411
E06.9 Thyroiditis, unspecified
0.000 0.595 0.404
E65-E68 Obesity and other hyperalimentation
0.000 0.599 0.401
I21.9 Acute myocardial infarction, unspecified
0.000 0.601 0.399
E23.7 Disorder of pituitary gland, unspecified
0.001 0.608 0.391
E12.9 Without complications
0.000 0.613 0.386
E12.8 With unspecified complications
0.000 0.613 0.386
E12.7 With multiple complications
0.000 0.613 0.386
E12.6 With other specified complications
0.000 0.613 0.386
E12.5 With peripheral circulatory complications
0.000 0.613 0.386
E12.4 With neurological complications
0.000 0.613 0.386
E12.3 With ophthalmic complications
0.000 0.613 0.386
E12.2 With renal complications
0.000 0.613 0.386
E12.1 With ketoacidosis
0.000 0.613 0.386
E12.0 With coma
0.000 0.613 0.386
E50-E64 Other nutritional deficiencies
0.000 0.614 0.386
I22.9 Subsequent myocardial infarction of unspecified site
0.000 0.618 0.382
E14.1 With ketoacidosis
0.000 0.618 0.382
C76.3 Pelvis
0.376 0.624 0.000
E22.0 Acromegaly and pituitary gigantism
0.000 0.626 0.374
E13.8 With unspecified complications
0.000 0.634 0.365
E13.7 With multiple complications
0.000 0.634 0.365
E13.6 With other specified complications
0.000 0.634 0.365
E13.5 With peripheral circulatory complications
0.000 0.634 0.365
E13.4 With neurological complications
0.000 0.634 0.365
E13.3 With ophthalmic complications
0.000 0.634 0.365
E13.2 With renal complications
0.000 0.634 0.365
E13.1 With ketoacidosis
0.000 0.634 0.365
E13.0 With coma
0.000 0.634 0.365
E14.8 With unspecified complications
0.000 0.635 0.365
E29.1 Testicular hypofunction
0.000 0.635 0.365
E15 Nondiabetic hypoglycaemic coma
0.000 0.650 0.350
E14.5 With peripheral circulatory complications
0.000 0.652 0.347
C76.1 Thorax
0.346 0.653 0.000
E14.2 Withrenal complications
0.000 0.655 0.345
E14.7 With multiple complications
0.000 0.656 0.344
E14.0 With coma
0.000 0.656 0.344
I20.8 Other forms of angina pectoris
0.000 0.663 0.337
E13.9 Without complications
0.000 0.664 0.336
E28.2 Polycystic ovarian syndrome
0.000 0.664 0.336
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
0.330 0.670 0.000
E14.6 With other specified complications
0.000 0.686 0.314
E07.1 Dyshormogenetic goitre
0.000 0.687 0.313
E07.0 Hypersecretion of calcitonin
0.000 0.687 0.313
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.691 0.308
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.303 0.696 0.001
E14.4 With neurological complications
0.000 0.699 0.300
E67 Other hyperalimentation
0.000 0.712 0.288
E68 Sequelae of hyperalimentation
0.000 0.712 0.288
E07.8 Other specified disorders of thyroid
0.000 0.713 0.287
E10.9 Without complications
0.000 0.717 0.283
C77.2 Intra-abdominal lymph nodes
0.278 0.722 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.723 0.277
E63 Other nutritional deficiencies
0.000 0.723 0.277
E50 Vitamin A deficiency
0.000 0.723 0.277
E60 Dietary zinc deficiency
0.000 0.723 0.277
E59 Dietary selenium deficiency
0.000 0.723 0.277
E58 Dietary calcium deficiency
0.000 0.723 0.277
E52 Niacin deficiency [pellagra]
0.000 0.723 0.277
E51 Thiamine deficiency
0.000 0.730 0.270
E53 Deficiency of other B group vitamins
0.000 0.730 0.270
E56 Other vitamin deficiencies
0.000 0.735 0.265
E65 Localised adiposity
0.000 0.743 0.257
E55 Vitamin D deficiency
0.000 0.748 0.252
I21.4 Acute subendocardial myocardial infarction
0.000 0.753 0.247
E53.9 Vitamin B deficiency, unspecified
0.000 0.764 0.236
E61 Deficiency of other nutrient elements
0.000 0.775 0.225
E54 Ascorbic acid deficiency
0.000 0.780 0.220
C79.9 Secondary malignant neoplasm, unspecified site
0.210 0.789 0.001
E67.8 Other specified hyperalimentation
0.000 0.793 0.206
E67.3 Hypervitaminosis D
0.000 0.793 0.206
E67.2 Megavitamin-B6 syndrome
0.000 0.793 0.206
E67.1 Hypercarotenaemia
0.000 0.793 0.206
E67.0 Hypervitaminosis A
0.000 0.793 0.206
C80.0 Malignant neoplasm, primary site unknown, so stated
0.199 0.801 0.000
E50.9 Vitamin A deficiency, unspecified
0.000 0.801 0.199
E50.8 Other manifestations of vitamin A deficiency
0.000 0.801 0.199
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.801 0.199
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.801 0.199
E50.5 Vitamin A deficiency with night blindness
0.000 0.801 0.199
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.801 0.199
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.801 0.199
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.801 0.199
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.801 0.199
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.801 0.199
E63.9 Nutritional deficiency, unspecified
0.000 0.801 0.199
E63.8 Other specified nutritional deficiencies
0.000 0.801 0.199
E63.1 Imbalance of constituents of food intake
0.000 0.801 0.199
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.801 0.199
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.801 0.199
E64.8 Sequelae of other nutritional deficiencies
0.000 0.801 0.199
E64.3 Sequelae of rickets
0.000 0.801 0.199
E64.2 Sequelae of vitamin C deficiency
0.000 0.801 0.199
E64.1 Sequelae of vitamin A deficiency
0.000 0.801 0.199
E64.0 Sequelae of protein-energy malnutrition
0.000 0.801 0.199
E51.9 Thiamine deficiency, unspecified
0.000 0.806 0.194
E51.8 Other manifestations of thiamine deficiency
0.000 0.806 0.194
E51.1 Beriberi
0.000 0.806 0.194
E53.1 Pyridoxine deficiency
0.000 0.806 0.193
E53.0 Riboflavin deficiency
0.000 0.806 0.193
E56.9 Vitamin deficiency, unspecified
0.000 0.810 0.190
E56.8 Deficiency of other vitamins
0.000 0.810 0.190
E56.0 Deficiency of vitamin E
0.000 0.810 0.190
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.810 0.190
E51.2 Wernicke's encephalopathy
0.000 0.813 0.187
E16 Other disorders of pancreatic internal secretion
0.000 0.816 0.184
E55.0 Rickets, active
0.000 0.819 0.181
E56.1 Deficiency of vitamin K
0.000 0.822 0.178
I24 Other acute ischaemic heart diseases
0.000 0.827 0.173
E61.9 Deficiency of nutrient element, unspecified
0.000 0.838 0.161
E61.8 Deficiency of other specified nutrient elements
0.000 0.838 0.161
E61.7 Deficiency of multiple nutrient elements
0.000 0.838 0.161
E61.6 Vanadium deficiency
0.000 0.838 0.161
E61.5 Molybdenum deficiency
0.000 0.838 0.161
E61.4 Chromium deficiency
0.000 0.838 0.161
E61.3 Manganese deficiency
0.000 0.838 0.161
E61.0 Copper deficiency
0.000 0.838 0.161
E55.9 Vitamin D deficiency, unspecified
0.000 0.844 0.156
E07.9 Disorder of thyroid, unspecified
0.000 0.845 0.154
E61.2 Magnesium deficiency
0.000 0.860 0.139
E61.1 Iron deficiency
0.000 0.861 0.139
E05.5 Thyroid crisis or storm
0.000 0.864 0.136
E05.4 Thyrotoxicosis factitia
0.000 0.864 0.136
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.864 0.136
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.864 0.136
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.868 0.132
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.868 0.132
E16.4 Abnormal secretion of gastrin
0.000 0.868 0.132
E16.3 Increased secretion of glucagon
0.000 0.868 0.132
E05.8 Other thyrotoxicosis
0.000 0.872 0.128
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.874 0.126
E16.1 Other hypoglycaemia
0.000 0.879 0.121
I24.1 Dressler's syndrome
0.000 0.879 0.120
E66 Obesity
0.000 0.886 0.113
I20.0 Unstable angina
0.000 0.895 0.105
E66.0 Obesity due to excess calories
0.000 0.902 0.098
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.910 0.089
E05.9 Thyrotoxicosis, unspecified
0.000 0.913 0.087
I24.9 Acute ischaemic heart disease, unspecified
0.000 0.917 0.083
E66.1 Drug-induced obesity
0.000 0.918 0.081
E53.8 Deficiency of other specified B group vitamins
0.000 0.919 0.081
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.921 0.079
E14.9 Without complications
0.000 0.930 0.070
I24.0 Coronary thrombosis not resulting in myocardial infarction
0.000 0.931 0.068
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.936 0.064
S72.00 Fracture of neck of femur (closed)
0.000 0.948 0.052
E04 Other non-toxic goitre
0.001 0.951 0.048
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.048 0.952 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.045 0.955 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.045 0.955 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.045 0.955 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.043 0.957 0.000
C83.0 Small cell (diffuse)
0.043 0.957 0.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.958 0.042
S72.0 Fracture of neck of femur
0.000 0.960 0.040
C84.5 Other and unspecified T-cell lymphomas
0.039 0.961 0.000
C92 Myeloid leukaemia
0.039 0.961 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.039 0.961 0.000
C84.4 Peripheral T-cell lymphoma
0.039 0.961 0.000
C83.7 Burkitt's tumour
0.039 0.961 0.000
C86 Other specified types of T/NK-cell lymphoma
0.038 0.962 0.000
C95 Leukaemia of unspecified cell type
0.038 0.962 0.000
C85.1 B-cell lymphoma, unspecified
0.038 0.962 0.000
C88 Malignant immunoproliferative diseases
0.038 0.962 0.000
C83.5 Lymphoblastic (diffuse)
0.037 0.963 0.000
C93 Monocytic leukaemia
0.037 0.963 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.037 0.963 0.000
C81 Hodgkin's disease
0.037 0.963 0.000
E11.1 With ketoacidosis
0.000 0.963 0.037
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.036 0.964 0.000
E04.8 Other specified non-toxic goitre
0.001 0.965 0.034
C92.1 Chronic myeloid leukaemia
0.035 0.965 0.000
C84.0 Mycosis fungoides
0.035 0.965 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.034 0.965 0.000
C94 Other leukaemias of specified cell type
0.034 0.965 0.000
E11.8 With unspecified complications
0.000 0.965 0.034
C90.1 Plasma cell leukaemia
0.034 0.966 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.033 0.967 0.000
C85.0 Lymphosarcoma
0.033 0.967 0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.967 0.033
C83.6 Undifferentiated (diffuse)
0.033 0.967 0.000
C83.4 Immunoblastic (diffuse)
0.033 0.967 0.000
C83.2 Mixed small and large cell (diffuse)
0.033 0.967 0.000
C81.1 Nodular sclerosis
0.033 0.967 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.032 0.967 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.032 0.967 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.032 0.967 0.000
C84.3 Lymphoepithelioid lymphoma
0.032 0.967 0.000
C84.2 T-zone lymphoma
0.032 0.967 0.000
C84.1 Sezary's diease
0.032 0.967 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.032 0.968 0.000
E11.0 With coma
0.000 0.968 0.032
S72 Fracture of femur
0.000 0.968 0.032
C84.8 Cutaneous T-cell lymphoma, unspecified
0.031 0.969 0.000
C90.3 Solitary plasmacytoma
0.031 0.969 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.031 0.969 0.000
C90.2 Plasmacytoma, extramedullary
0.030 0.969 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.030 0.969 0.000
I24.8 Other forms of acute ischaemic heart disease
0.000 0.970 0.030
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.030 0.970 0.000
S72.3 Fracture of shaft of femur
0.000 0.970 0.030
C92.9 Myeloid leukaemia, unspecified
0.030 0.970 0.000
S72.01 Fracture of neck of femur (open)
0.000 0.971 0.029
C93.1 Chronic monocytic leukaemia
0.029 0.971 0.000
C81.7 Other Hodgkin's disease
0.029 0.971 0.000
S72.30 Fracture of shaft of femur (closed)
0.000 0.971 0.029
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.029 0.971 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.028 0.972 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.028 0.972 0.000
C92.5 Acute myelomonocytic leukaemia
0.028 0.972 0.000
C92.3 Myeloid sarcoma
0.028 0.972 0.000
C92.2 Subacute myeloid leukaemia
0.028 0.972 0.000
C91 Lymphoid leukaemia
0.028 0.972 0.000
C92.7 Other myeloid leukaemia
0.028 0.972 0.000
C81.0 Lymphocytic predominance
0.028 0.972 0.000
C95.9 Leukaemia, unspecified
0.028 0.972 0.000
E04.0 Non-toxic diffuse goitre
0.001 0.972 0.027
S72.1 Pertrochanteric fracture
0.000 0.972 0.028
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.027 0.972 0.000
C86.4 Blastic NK-cell lymphoma
0.027 0.972 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.027 0.972 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.027 0.972 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.027 0.972 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.027 0.972 0.000
C95.7 Other leukaemia of unspecified cell type
0.027 0.972 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.027 0.972 0.000
C95.0 Acute leukaemia of unspecified cell type
0.027 0.972 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.027 0.973 0.000
C88.7 Other malignant immunoproliferative diseases
0.027 0.973 0.000
C88.3 Immunoproliferative small intestinal disease
0.027 0.973 0.000
C88.2 Gamma heavy chain disease
0.027 0.973 0.000
C88.1 Alpha heavy chain disease
0.027 0.973 0.000
C92.4 Acute promyelocytic leukaemia
0.027 0.973 0.000
C93.9 Monocytic leukaemia, unspecified
0.027 0.973 0.000
C93.7 Other monocytic leukaemia
0.027 0.973 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.027 0.973 0.000
C93.2 Subacute monocytic leukaemia
0.027 0.973 0.000
C93.0 Acute monocytic leukaemia
0.027 0.973 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.027 0.973 0.000
C81.3 Lymphocytic depletion
0.027 0.973 0.000
C94.7 Other specified leukaemias
0.025 0.975 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.025 0.975 0.000
C94.5 Acute myelofibrosis
0.025 0.975 0.000
C94.4 Acute panmyelosis
0.025 0.975 0.000
C94.3 Mast cell leukaemia
0.025 0.975 0.000
C94.2 Acute megakaryoblastic leukaemia
0.025 0.975 0.000
C94.1 Chronic erythraemia
0.025 0.975 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.025 0.975 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.025 0.975 0.000
C96.8 Histiocytic sarcoma
0.025 0.975 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.025 0.975 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.025 0.975 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.025 0.975 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.025 0.975 0.000
C96.3 True histiocytic lymphoma
0.025 0.975 0.000
C96.2 Malignant mast cell tumour
0.025 0.975 0.000
C96.1 Malignant histiocytosis
0.025 0.975 0.000
C96.0 Letterer-Siwe disease
0.025 0.975 0.000
E11.7 With multiple complications
0.000 0.975 0.025
E11.2 With renal complications
0.000 0.975 0.025
S72.10 Pertrochanteric fracture (closed)
0.000 0.975 0.025
C81.2 Mixed cellularity
0.024 0.975 0.000
S72.4 Fracture of lower end of femur
0.000 0.976 0.024
C82.1 Mixed small cleaved and large cell, follicular
0.024 0.976 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.024 0.976 0.000
E16.2 Hypoglycaemia, unspecified
0.000 0.976 0.024
C83.1 Small cleaved cell (diffuse)
0.023 0.976 0.000
C92.0 Acute myeloid leukaemia
0.023 0.977 0.000
S72.7 Multiple fractures of femur
0.000 0.977 0.023
C91.5 Adult T-cell leukaemia
0.023 0.977 0.000
C91.9 Lymphoid leukaemia, unspecified
0.023 0.977 0.000
C82.3 Follicular lymphoma grade IIIa
0.023 0.977 0.000
E11.6 With other specified complications
0.000 0.977 0.023
C82.0 Small cleaved cell, follicular
0.022 0.978 0.000
S72.9 Fracture of femur, part unspecified
0.000 0.978 0.022
M05.9 Seropositive rheumatoid arthritis, unspecified
0.000 0.978 0.022
C82.6 Cutaneous follicle centre lymphoma
0.021 0.979 0.000
C82.5 Diffuse follicle centre lymphoma
0.021 0.979 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.020 0.979 0.000
C91.7 Other lymphoid leukaemia
0.020 0.979 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.020 0.979 0.000
C91.3 Prolymphocytic leukaemia
0.020 0.979 0.000
C91.2 Subacute lymphocytic leukaemia
0.020 0.979 0.000
C82.4 Follicular lymphoma grade IIIb
0.020 0.979 0.000
S72.31 Fracture of shaft of femur (open)
0.000 0.979 0.020
S72.40 Fracture of lower end of femur (closed)
0.000 0.979 0.020
S72.8 Fractures of other parts of femur
0.000 0.980 0.020
S72.11 Pertrochanteric fracture (open)
0.000 0.980 0.020
C91.0 Acute lymphoblastic leukaemia
0.020 0.980 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.